D
Telix Pharmaceuticals Limited TLX
$9.36 -$0.07-0.74% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -1.15M -1.15M 6.60M 6.79M 7.60M
Total Depreciation and Amortization 4.79M 4.79M 1.41M 1.45M 1.59M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 5.23M 5.23M 14.22M 14.62M 10.49M
Change in Net Operating Assets -- -- -20.94M -21.53M --
Cash from Operations 8.87M 8.87M 1.29M 1.32M 19.68M
Capital Expenditure -3.33M -3.33M -3.14M -3.23M -1.48M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -114.84M -114.84M -3.73M -3.84M -15.57M
Divestitures -- -- -- -- --
Other Investing Activities -11.26M -11.26M -22.23M -22.86M -7.43M
Cash from Investing -129.43M -129.43M -29.11M -29.93M -24.48M
Total Debt Issued -- -- 326.62M 326.62M 990.40K
Total Debt Repaid -1.80M -1.80M -974.50K -974.50K -787.00K
Issuance of Common Stock 338.00K 338.00K 182.50K 182.50K 311.20K
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -7.44M -7.44M 1.88M
Cash from Financing -1.46M -1.46M 207.47M 213.33M 2.40M
Foreign Exchange rate Adjustments 5.59M 5.59M 13.07M 13.44M -2.53M
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -116.42M -116.42M 192.72M 198.17M -4.93M